SANUWAVE Health, Inc.

Stage 4 · Declining · week 46

As of Oct 22, 2026, SANUWAVE Health is in Stage 4, the downtrend phase, now in week 46 (since Nov 28, 2025). It closed at $5.30, 85.0% below its 52-week high and below its 200-day average, which is falling.

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. More about the company

$5.30

-0.75% today

$45.6M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is SNWV early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2024-10-18 → 2026-10-22

S? 42w

S2 9w

S4 47w

2024-10-182026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S2 9w → S3 7w → S4 47w current

Total tracked: 105 weeks across 4 stage runs.

SNWV among Medical Devices112th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…112	SNWVSANUWAVE Health, Inc.	Stage 4 · wk 46	10	+12.6%

vs 52W High

-85.0%

$4.00 lo$35.34 hi

85.0% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 46

1w13w26w

Week 46, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-62.7%

200 DMA: $14.23 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.26x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+12.6%

-10.6%

-72.3%

YTD

-81.7%

-82.5%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S4

Wk 46 · Vol 0.26x

2026-10-21S4

Wk 45 · Vol 0.22x

2026-10-20S4

Wk 45 · Vol 0.77x

2026-10-19S4

Wk 45 · Vol 0.88x

2026-10-16S4

Wk 45 · Vol 0.86x

2026-10-15S4

Wk 45 · Vol 0.59x

2026-10-14S4

Wk 44 · Vol 0.74x

2026-10-13S4

Wk 44 · Vol 0.46x

2026-10-12S4

Wk 44 · Vol 1.23x

2026-10-09S4

Wk 44 · Vol 0.32x

2026-10-08S4

Wk 44 · Vol 0.87x

2026-10-07S4

Wk 43 · Vol 1.39x

Moving averages & range

50 DMA

$4.79

200 DMA

$14.23

52W High

$35.34

52W Low

$4.00

5D Low

$4.83

Resistance levels (recent highs)

20d High

$5.85

60d High

$6.31

120d High

$18.94

250d High

$35.34

Next resistance

+10.3%

to 20d High

P/E (TTM)

22.1

Forward -530.0

Dividend Yield

0.00%

P/B 16.4

SANUWAVE Health: quick answers

What stage is SANUWAVE Health in?

As of Oct 22, 2026, SANUWAVE Health (SNWV) is in Stage 4, the downtrend phase. It entered Stage 4 on Nov 28, 2025 and is in week 46. What the four stages mean

Is SANUWAVE Health in an uptrend?

No. SANUWAVE Health is in a Stage 4 downtrend. It trades 62.7% below its 200-day average, which is falling.

How far is SANUWAVE Health from its 52-week high?

SANUWAVE Health closed at $5.30 on Oct 22, 2026, 85.0% below its 52-week high of $35.34. Its 52-week low is $4.00.

How has SANUWAVE Health performed over the past year?

As of Oct 22, 2026, SANUWAVE Health is down 82.5% over the past year and down 81.7% so far in 2026.

Which sector and industry is SANUWAVE Health in?

SANUWAVE Health is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.